SSA
KMTS

Schonfeld Strategic Advisors’s Kestra Medical Technologies KMTS Stock Holding History

Schonfeld Strategic Advisors’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.27M Buy
+113,863
New +$2.68M 0.02% 769
2025
Q3 		– Sell
-71,074
Closed -$1.18M – 2674
2025
Q2 		$1.18M Buy
71,074
+36,110
+103% +$788K 0.01% 1234
2025
Q1 		$871K Buy
+34,964
New +$803K 0.01% 1344

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Schonfeld Strategic Advisors's KMTS Position: Q1 2026 in Review

Schonfeld Strategic Advisors opened a new position in Kestra Medical Technologies (KMTS) in Q1 2026: 113,863 shares worth $2.27M. The stake represents 0.02% of the portfolio and ranks #769 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in KMTS as recently as Q2 2025.

Schonfeld Strategic Advisors first reported a position in KMTS in Q1 2025 and has held it in 3 quarters since. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Schonfeld Strategic Advisors held 113,863 shares of Kestra Medical Technologies worth $2.27M as of Q1 2026.
  • Kestra Medical Technologies was a new Schonfeld Strategic Advisors position in Q1 2026.
  • Kestra Medical Technologies made up 0.02% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #769 holding.
  • Schonfeld Strategic Advisors first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 3 quarters since.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.